CLINICAL_TRIALS
trial_result
· 2022-08-01
Clinical Trial Update: OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001 [Phase 2]
Summary
Phase 2 open-label study update for ANAVEX2-73 in Parkinson's disease with dementia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anavex Life Sciences Corp. | Conditions: Parkinson Disease Dementia | Phase 2 | Status: COMPLETED